BOLT BIOTHERAPEUTICS INC (BOLT) Stock Balance Sheet
NASDAQ:BOLT - Nasdaq - US0977021049 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.37M | 10.81M | 9.20M | 27.40M | 5.50M | |||
| Marketable Securities | 44.43M | 91.38M | 159.60M | 158.80M | 17.30M | |||
| Other Current Assets | 3.35M | 3.52M | 3.90M | 2.90M | 2.50M | |||
| Total Current Assets | 57.15M | 105.71M | 172.70M | 189.20M | 25.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.32M | 24.08M | 28.50M | 30.60M | 16.40M | |||
| Investments And Advances | 30.60M | 26.41M | 23.90M | 85.30M | N/A | |||
| Other Non-Current Assets | 1.27M | 3.59M | 2.60M | 2.60M | 4.80M | |||
| Total Non-Current Assets | 52.19M | 54.08M | 55.10M | 118.50M | 21.10M | |||
| TOTAL ASSETS | 109.33M | 159.78M | 227.80M | 307.70M | 46.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 14.63M | 15.27M | 17.50M | 14.90M | 8.20M | |||
| Accounts Payable | 1.48M | 2.99M | 3.60M | 3.60M | 1.60M | |||
| Other Current Liabilities | 1.97M | 2.20M | 2.00M | 2.90M | 1.50M | |||
| Total Current Liabilities | 18.08M | 20.46M | 23.10M | 21.30M | 11.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 19.22M | 26.59M | 33.20M | 36.30M | 34.90M | |||
| Total Non-Current Liabilities | 19.22M | 26.59M | 33.20M | 36.30M | 34.90M | |||
| TOTAL LIABILITIES | 37.30M | 47.04M | 56.30M | 57.60M | 46.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -411.47M | -364.29M | -295.10M | -207.00M | -108.40M | |||
| Additional Paid In Capital | 483.29M | 476.99M | 467.50M | 457.40M | 3.50M | |||
| Common Shares | 1.00K | 1.00K | 0.00 | 0.00 | 105.30M | |||
| Other Shareholders' Equity | 205.00K | 37.00K | -900.00K | -300.00K | 0.00 | |||
| Shares Outstanding | 38.27M | 38.11M | 37.80M | 37.40M | 36.30M | |||
| Tangible Book Value per Share | 1.88 | 2.96 | 4.54 | 6.69 | -2.89 | |||
| Total Shareholders' Equity | 72.03M | 112.74M | 171.50M | 250.10M | 300.00K | |||
| TOTAL LIABILITIES AND EQUITY | 109.33M | 159.78M | 227.80M | 307.70M | 46.50M | |||
| Statistics | ||||||||
| Current Ratio | 3.16 | 5.17 | 7.48 | 8.88 | 2.25 | |||
| Return On Assets (ROA) | -59.53% | -43.31% | -38.67% | -32.04% | -130.60% | |||
| Return On Equity (ROE) | -90.36% | -61.38% | -51.37% | -39.42% | -20243.33% | |||
All data in USD , ROIC based on taxRate of 0.21